Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies

References

• Humblet-Baron S, Franckaert D, Dooley J, et al. FN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2019;143(6):2215–2226.e7. doi:10.1016/j.jaci.2018.10.068
   PubMed Web of Science ®Google Scholar
• Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program. 2013;2013(1):605–611. doi:10.1182/asheducation-2013.1.605
   PubMed Web of Science ®Google Scholar
• Yildiz H, Van Den Neste E, Defour JP, Danse E, Yombi JC. Adult haemophagocytic lymphohistiocytosis: a review. QJM. 2020. doi:10.1093/qjmed/hcaa011
   PubMed Web of Science ®Google Scholar
• La Rosée P, Horne AC, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477. doi:10.1182/blood.2018894618
   PubMed Web of Science ®Google Scholar
• Miao Y, Zhu HY, Qiao C, et al. Pathogenic gene mutations or variants identified by targeted gene sequencing in adults with hemophagocytic lymphohistiocytosis. Front Immunol. 2019;10:395. doi:10.3389/fimmu.2019.00395
   PubMed Web of Science ®Google Scholar
• Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult onset familial HLH. Blood. 2011;118(22):5794–5798. doi:10.1182/blood-2011-07-370148
   PubMed Web of Science ®Google Scholar
• Chen X, Wang F, Zhang Y, et al. Genetic variant spectrum in 265 Chinese patients with hemophagocytic lymphohistiocytosis: molecular analyses of PRF1, UNC13D, STX11, STXBP2, SH2D1A, and XIAP. Clin Genet. 2018;94(2):200–212. doi:10.1111/cge.13363
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516. doi:10.1016/S0140-6736(13)61048-X
   PubMed Web of Science ®Google Scholar
• Sepulveda FE, de Saint Basile G. Hemophagocytic syndrome: primary forms and predisposing conditions. Curr Opin Immunol. 2017;49:20–26. doi:10.1016/j.coi.2017.08.004
   PubMed Web of Science ®Google Scholar
• Brisse E, Wouters CH, Matthys P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br J Haematol. 2016;174(2):203–217. doi:10.1111/bjh.14147
   PubMed Web of Science ®Google Scholar
• Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439–446. doi:10.1007/s11926-014-0439-2
   PubMed Web of Science ®Google Scholar
• Carvelli J, Piperoglou C, Farnarier C, et al. Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect. Blood. 2020;136(5):542–552. doi:10.1182/blood.2019003664
   PubMed Web of Science ®Google Scholar
• Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood. 2013;121(26):5184–5191. doi:10.1182/blood-2013-04-495309
   PubMed Web of Science ®Google Scholar
• Rood JE, Rao S, Paessler M, et al. ST2 contributes to T cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood. 2016;127(4):426–435. doi:10.1182/blood-2015-07-659813
   PubMed Web of Science ®Google Scholar
• Mao H, Tu W, Qin G, et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol. 2009;83(18):9215–9222. doi:10.1128/JVI.00805-09
   PubMed Web of Science ®Google Scholar
• Jenkins MR, Rudd-Schmidt JA, Lopez JA, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212(3):307–317. doi:10.1084/jem.20140964
   PubMed Web of Science ®Google Scholar
• Vastert SJ, van Wijk R, D’Urbano LE, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). 2010;49(3):441–449. doi:10.1093/rheumatology/kep418
   PubMed Web of Science ®Google Scholar
• Kaufman KM, Linghu B, Szustakowski JD, et al. Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheum. 2014;66(12):3486–3495. doi:10.1002/art.38793
   PubMed Web of Science ®Google Scholar
• Sieni E, Cetica V, Piccin A, et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series. PLoS One. 2012;7(9):e44649. doi:10.1371/journal.pone.0044649
   PubMed Web of Science ®Google Scholar
• Cetica V, Sieni E, Pende D, et al. Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry. J Allergy Clin Immunol. 2016;137(1):188–196.e4. doi:10.1016/j.jaci.2015.06.048
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol Mech Dis. 2018;13(1):1.1–1.23. doi:10.1146/annurev-pathol-020117-043625
   PubMed Web of Science ®Google Scholar
• Fazal F, Gupta N, Mittal A, Ray A. Haemophagocytic lymphohistiocytosis in human immunodeficiency virus: a systematic review of literature. Drug Discov Ther. 2020;14(5):226–231. doi:10.5582/ddt.2020.03069
   PubMed Web of Science ®Google Scholar
• Machaczka M, Vaktnäs J, Klimkowska M, Hägglund H. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma. 2011;52(4):613–619. doi:10.3109/10428194.2010.551153
   PubMed Web of Science ®Google Scholar
• Ravelli A, Davì S, Minoia F, Martini A, Cron RQ. Macrophage Activation Syndrome. Hematol Oncol Clin North Am. 2015;29(5):927–941. doi:10.1016/j.hoc.2015.06.010
   PubMed Web of Science ®Google Scholar
• Sadaat M, Jang S. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report. J Immunother Cancer. 2018;6(1):49. doi:10.1186/s40425-018-0365-3
   PubMed Web of Science ®Google Scholar
• Laderian B, Koehn K, Holman C, Lyckholm L, Furqan M. Association of hemophagocytic lymphohistiocytosis and programmed death 1 checkpoint inhibitors. J Thorac Oncol. 2019;14(4):e77–e78. doi:10.1016/j.jtho.2018.11.035
   PubMed Web of Science ®Google Scholar
• Moon YW, Hajjar J, Hwu P, Naing A. Targeting the indoleamine 2,3-dioxygenase pathway in cancer. J Immunother Cancer. 2015;3(1):51. doi:10.1186/s40425-015-0094-9
   PubMed Web of Science ®Google Scholar
• Put K, Brisse E, Avau A, et al. IDO1 deficiency does not affect disease in mouse models of systemic juvenile idiopathic arthritis and secondary hemophagocytic lymphohistiocytosis. PLoS One. 2016;11(2):e0150075. doi:10.1371/journal.pone.0150075
   PubMed Web of Science ®Google Scholar
• Hayden A, Park S, Giustini D, Lee AY, Chen LY. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30(6):411–420. doi:10.1016/j.blre.2016.05.001
   PubMed Web of Science ®Google Scholar
• Karras A, Thervet E, Le Meur Y, Baudet-Bonneville V, Kessler M, Legendre C. Successful renal retransplantation after post-transplant lymphoproliferative disease. Am J Transplant. 2004;4(11):1904–1909. doi:10.1111/j.1600-6143.2004.00562.x
   PubMed Web of Science ®Google Scholar
• Fardet L, Galicier L, Lambotte O, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613–2620. doi:10.1002/art.38690
   PubMed Web of Science ®Google Scholar
• Debaugnies F, Mahadeb B, Ferster A, et al. Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol. 2016;145(6):862–870. doi:10.1093/ajcp/aqw076
   PubMed Web of Science ®Google Scholar
• Chaturvedi V, Marsh RA, Lorenz AZ, et al. T cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis. Blood. 2020:blood.2020009499. PMID: 33512385. doi:10.1182/blood.2020009499
   Web of Science ®Google Scholar
• Abdalgani M, Filipovich AH, Choo S, et al. Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations. Blood. 2015;126(15):1858–1860. doi:10.1182/blood-2015-06-648659
   PubMed Web of Science ®Google Scholar
• Rubin TS, Zhang K, Gifford C, et al. Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH. Blood. 2017;129(22):2993–2999. doi:10.1182/blood-2016-12-753830
   PubMed Web of Science ®Google Scholar
• Merli P, Gentile L, Quagliarella F, et al. QuantiFERON-TB Gold can help clinicians in the diagnosis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2020;191(2):e64–e67. doi:10.1111/bjh.17001
   PubMed Web of Science ®Google Scholar
• Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain K. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041–4052. doi:10.1182/blood-2011-03-278127
   PubMed Web of Science ®Google Scholar
• Ehl S, Astigarraga I, von Bahr Greenwood T, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6(5):1508–1517. doi:10.1016/j.jaip.2018.05.031
   PubMed Web of Science ®Google Scholar
• Trottestam H, Horne A, Arico M, et al.; Histiocyte Society. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577–4584. doi:10.1182/blood-2011-06-356261
   PubMed Web of Science ®Google Scholar
• La Rosée P. Treatment of hemophagocytic lymphohistiocytosis in adults. Hematology Am Soc Hematol Educ Program. 2015;2015(1):190–196. doi:10.1182/asheducation-2015.1.190
   PubMed Web of Science ®Google Scholar
• Daver N, McClain K, Allen CE, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123(17):3229–3240. doi:10.1002/cncr.30826
   PubMed Web of Science ®Google Scholar
• Guangqiang M, Wang Y, Wang J, Wang Z. The DEP regimen is superior to the HLH-1994 regimen as first-line therapy for lymphoma-associated haemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2020. doi:10.1080/10428194.2020.1849671
   Web of Science ®Google Scholar
• Delavigne K, Bérard E, Bertoli S, et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica. 2014;99(3):474–480. doi:10.3324/haematol.2013.097394
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang W, Hu L, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015;126(19):2186–2192. doi:10.1182/blood-2015-05-644914
   PubMed Web of Science ®Google Scholar
• Marsh RA, Allen CE, McClain KL, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013;60(1):101–109. doi:10.1002/pbc.24188
   PubMed Web of Science ®Google Scholar
• Yuan L, Kan Y, Meeks JK, Ma D, Yang J. 18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis. Diagn Interv Radiol. 2016;22(5):471–475. doi:10.5152/dir.2016.15226
   PubMed Web of Science ®Google Scholar
• Zheng Y, Hu G, Liu Y, et al. The role of 18F-FDG PET CT in the management of patients with secondary haemophagocytic lymphohistiocytosis. Clin Radiol. 2016;71(12):1248–1254. doi:10.1016/j.crad.2016.05.011
   PubMed Web of Science ®Google Scholar
• Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367–2373. doi:10.1182/blood-2002-01-0172
   PubMed Web of Science ®Google Scholar
• Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol. 2005;129(5):622–630. doi:10.1111/j.1365-2141.2005.05501.x
   PubMed Web of Science ®Google Scholar
• Bergsten E, Horne A, Hed Myrberg I, et al. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study. Blood Adv. 2020;4(15):3754–3766. doi:10.1182/bloodadvances.2020002101
   PubMed Web of Science ®Google Scholar
• Li Z, Wang Y, Wang J, Zhang J, Wang Z. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2018;59(1):77–84. doi:10.1080/10428194.2017.1330467
   PubMed Web of Science ®Google Scholar
• Oliansky DM, Czuczman M, Fisher RI, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biol Blood Marrow Transplant. 2011;17(1):20–47. doi:10.1016/j.bbmt.2010.07.008
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Wu L, Zhang J, Lai W, Wang Z. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Hematol Oncol. 2016;9(1):84. doi:10.1186/s13045-016-0317-7
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi J, Li X, et al. Salvage therapy with dose-escalating ruxolitinib as bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2020;55(4):824–826. doi:10.1038/s41409-019-0577-2
   PubMed Web of Science ®Google Scholar
• Locatelli F, Jordan MB, Allen CE, et al. Emapalumab in Children with primary hemophagocytic lymphohistiocytosis. N Engl J Med. 2020;382(19):1811–1822. doi:10.1056/NEJMoa1911326
   PubMed Web of Science ®Google Scholar
• Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis. Blood. 2019;134(21):1783–1786. doi:10.1182/blood.2019002289
   PubMed Web of Science ®Google Scholar
• Meyer LK, Verbist KC, Albeituni S, et al. JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood. 2020;136(6):657–668. doi:10.1182/blood.2020006075
   PubMed Web of Science ®Google Scholar
• Sin JH, Zangardi ML. Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: first case report. Hematol Oncol Stem Cell Ther. 2019;12(3):166–170. doi:10.1016/j.hemonc.2017.07.002
   PubMedGoogle Scholar
• Wang J, Wang Y, Wu L, et al. Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis. Haematologica. 2020;105(5):e210. doi:10.3324/haematol.2019.222471
   PubMed Web of Science ®Google Scholar
• Ahmed A, Merrill SA, Alsawah F, et al. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol. 2019;6(12):e630–e637. doi:10.1016/S2352-3026(19)30156-5
   PubMed Web of Science ®Google Scholar
• Boonstra PS, Ahmed A, Merrill SA, Wilcox RA. Ruxolitinib in adult patients with secondary hemophagocytic lymphohistiocytosis. Am J Hematol. 2021;96(4). doi:10.1002/ajh.26091
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Z. Multicenter study of ruxolitinib combined DEP regimen as a salvage therapy for refractory/relapsed hemophagocytic lymphohistiocytosis. Blood. 2019;134(Supplement_1):1042. doi:10.1182/blood-2019-130980
   Web of Science ®Google Scholar
• Kim ST, Cristescu R, Bass AJ, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449–1458. doi:10.1038/s41591-018-0101-z
   PubMed Web of Science ®Google Scholar
• Liu P, Pan X, Chen C, et al. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Blood. 2020;135(11):826–833. doi:10.1182/blood.2019003886
   PubMed Web of Science ®Google Scholar
• Saarela M, Senthil K, Jones J, et al. Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab. Neurology. 2018;90(18):849–851. doi:10.1212/WNL.0000000000005420
   PubMed Web of Science ®Google Scholar
• So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus. Mod Rheumatol. 2014;24(5):855–857. doi:10.3109/14397595.2013.874740
   PubMed Web of Science ®Google Scholar
• Henzan T, Nagafuji K, Tsukamoto H, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81(1):59–61. doi:10.1002/ajh.20462
   PubMed Web of Science ®Google Scholar
• Lorenz G, Schul L, Schraml F, et al. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: ‘of plasma exchange and immunosuppressive escalation strategies’ - a single centre reflection. Lupus. 2020;29(3):324–333. doi:10.1177/0961203320901594
   PubMed Web of Science ®Google Scholar